OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
May 28, 2020
CordenPharma and Moderna extended a strategic manufacturing services agreement for the supply of lipid excipients to be used in Moderna’s vaccine against SARS-CoV-2.
Advent manufactured the vaccine doses for the Phase 2/3 clinical trial.
May 18, 2020
Vibalogics is contracted to manufacture Janssen's COVID-19 candidate vaccine at its GMP-accredited facility in Cuxhaven, Germany.
May 06, 2020
CMO Evonik begins capacity expansion of APIs and intermediates at its sites in Dossenheim and Hanau Germany to increase EU supply security for drug products.
May 05, 2020
Catalent will manufacture a mRNA-based COVID-19 vaccine for clinical trials and potential commercialization.
May 04, 2020
Fujifilm allocates production volumes for COVID-19 treatments in 2021 at its Denmark facility.
May 02, 2020
Experience, communication, collaboration, transparency, planning, and prioritization contribute to success.
May 01, 2020
The goal of the collaboration is to manufacture up to one billion does per year of mRNA-1273, Moderna’s vaccine against the novel coronavirus.
Manja Boerman tapped as president of Cell & Gene Therapy for Catalent with retirement of Pete Buzy.
April 30, 2020
Private equity firm, Ampersand Capital Partners, has made a majority investment into contract packaging organization (CPO), Tjoapack.